BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 10572908)

  • 1. The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy.
    Burak Z; Yüksel DA; Cetingül N; Kantar M; Ozkiliç H; Moretti JL
    Nucl Med Commun; 1999 Nov; 20(11):991-1000. PubMed ID: 10572908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.
    El-Maghraby T
    Gulf J Oncolog; 2007 Jul; (2):33-41. PubMed ID: 20084722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
    Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the utility of
    Gauguet JM; Pace-Emerson T; Grant FD; Shusterman S; DuBois SG; Frazier AL; Voss SD
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False-negative scintigraphy with Tc-99m sestamibi in stage IV neuroblastoma.
    Ozcan Z; Erenel G; Aksoylar S; Kansoy S; Burak Z; Ozkiliç H
    Clin Nucl Med; 1999 Apr; 24(4):267-70. PubMed ID: 10466525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients.
    Hoefnagel CA; Rutgers M; Buitenhuis CK; Smets LA; de Kraker J; Meli M; Carrel F; Amstutz H; Schubiger PA; Novak-Hofer I
    Eur J Nucl Med; 2001 Mar; 28(3):359-68. PubMed ID: 11315605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma.
    Perel Y; Conway J; Kletzel M; Goldman J; Weiss S; Feyler A; Cohn SL
    J Pediatr Hematol Oncol; 1999; 21(1):13-8. PubMed ID: 10029806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy.
    Turba E; Fagioli G; Mancini AF; Rosito P; Galli A; Alvisi P
    J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
    Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
    Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
    Dhull VS; Sharma P; Patel C; Kundu P; Agarwala S; Bakhshi S; Bhatnagar V; Bal C; Kumar R
    Nucl Med Commun; 2015 Oct; 36(10):1007-13. PubMed ID: 26049371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
    Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
    Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].
    Lumbroso J; Guermazi F; Hartmann O; Coornaert S; Rabarison Y; Lemerle J; Parmentier C
    Bull Cancer; 1988; 75(1):97-106. PubMed ID: 3359060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m sestamibi imaging in paediatric neuroblastoma and ganglioneuroma and its relation to P-glycoprotein.
    De Moerloose B; Van de Wiele C; Dhooge C; Philippé J; Speleman F; Benoit Y; Laureys G; Dierckx RA
    Eur J Nucl Med; 1999 Apr; 26(4):396-403. PubMed ID: 10199946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroblastoma: imaging evaluation by sequential Tc-99m MDP, I-131 MIBG, and Ga-67 citrate studies.
    Garty I; Friedman A; Sandler MP; Kedar A
    Clin Nucl Med; 1989 Jul; 14(7):515-22. PubMed ID: 2766633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.
    Shulkin BL; Shapiro B; Hutchinson RJ
    J Nucl Med; 1992 Oct; 33(10):1735-40. PubMed ID: 1403138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy.
    Alper E; Gurel M; Evrensel T; Ozkocaman V; Akbunar T; Demiray M
    Nucl Med Commun; 2003 May; 24(5):537-42. PubMed ID: 12717071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of metastatic bone disease with pentavalent 99Tc(m)-dimercaptosuccinic acid: a comparison with whole-body scanning and 4/24 hour quantitation of vertebral lesions.
    Sahin M; Basoglu T; Bernay I; Yapici O; Canbaz F; Yalin T
    Nucl Med Commun; 2000 Mar; 21(3):251-8. PubMed ID: 10823327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic impact of functional imaging with (123)I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: results of the German Neuroblastoma Trial NB97.
    Schmidt M; Simon T; Hero B; Schicha H; Berthold F
    Eur J Cancer; 2008 Jul; 44(11):1552-8. PubMed ID: 18424129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy.
    Boubaker A; Bischof Delaloye A
    Q J Nucl Med; 2003 Mar; 47(1):31-40. PubMed ID: 12714952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.